# RALGAPA1

## Overview
RALGAPA1 is a gene that encodes the Ral GTPase activating protein catalytic subunit alpha 1, a critical component of the RalGAP complex involved in the regulation of Ral GTPases, which are part of the Ras superfamily of small GTPases. The protein functions as a GTPase-activating protein (GAP), facilitating the conversion of RalA and RalB from their active GTP-bound states to inactive GDP-bound forms, thereby modulating various cellular processes such as intracellular-vesicle trafficking, cell migration, and insulin signaling (Wagner2020Biallelic; Chen2019Targeting). Structurally, RALGAPA1 contains a Rap/Ran-GAP domain, transmembrane domains, coiled-coil motifs, and a leucine zipper motif, which are essential for its interaction with other proteins and cellular components (Shimojima2009TULIP1). Mutations in RALGAPA1 have been linked to severe neurodevelopmental disorders and metabolic conditions, highlighting its significance in maintaining normal cellular and physiological functions (Wagner2020Biallelic; Chen2019Targeting).

## Structure
The RALGAPA1 protein, also known as the Ral GTPase activating protein catalytic subunit alpha 1, is involved in the regulation of Ral GTPases, which are part of the Ras superfamily of small GTPases. The protein contains a Rap/Ran-GAP domain, which is crucial for its function in facilitating GTP hydrolysis on RalA, converting it to an inactive form (Wagner2020Biallelic; Shimojima2009TULIP1). This domain is a key feature that contributes to the protein's role in the RalGAP complex, which includes a catalytic subunit (either RalGAPA1 or RalGAPA2) and a scaffolding subunit (RalGAPB) (Wagner2020Biallelic).

The protein also contains two putative transmembrane domains, two putative coiled-coil motifs, and a leucine zipper motif, which are structural features shared with its homologs in other species, such as zebrafish and mice (Shimojima2009TULIP1). These motifs suggest a complex tertiary structure that may facilitate interactions with other proteins and cellular components.

RALGAPA1 can exist in different isoforms due to alternative splicing, which may affect its function and interactions. For instance, in zebrafish, two splice variants, tulip1.1 and tulip1.2, have been identified, encoding proteins of different lengths (Shimojima2009TULIP1). The protein is also subject to post-translational modifications, such as phosphorylation, which can influence its activity and interactions within the cell (Chen2019Targeting).

## Function
RALGAPA1 encodes the catalytic subunit of the Ral GTPase-activating protein (GAP) complex, which is crucial for regulating the activity of RalA and RalB, two small G proteins involved in various cellular processes. In healthy human cells, RALGAPA1, as part of the RalGAP complex, maintains RalA in an inactive GDP-bound state, preventing its constitutive activation. This regulation is essential for normal cell physiology, including intracellular-vesicle trafficking, cell migration, establishment of cell polarity, neuronal polarity, and ciliogenesis (Wagner2020Biallelic).

The RalGAP complex is a heterodimer consisting of a catalytic subunit (either RalGAPA1 or RalGAPA2) and a scaffolding subunit (RalGAPB). Its proper function is necessary for the cycling of RalA between its active and inactive states. Disruption of RALGAPA1 leads to constitutive activation of RalA, which can result in severe neurodevelopmental disorders (Wagner2020Biallelic).

In skeletal muscle, RALGAPA1 plays a significant role in insulin signaling and glucose uptake. It is phosphorylated in response to insulin, which inactivates it and increases GTP-loaded active RalA, promoting the translocation of glucose transporter GLUT4 to the plasma membrane, facilitating glucose uptake (Chen2019Targeting). This process is crucial for maintaining whole-body metabolic homeostasis (Chen2019Targeting).

## Clinical Significance
Mutations in the RALGAPA1 gene are associated with a range of severe neurodevelopmental disorders. Bi-allelic variants in RALGAPA1 have been linked to profound neurodevelopmental disabilities, muscular hypotonia, infantile spasms, and feeding abnormalities. Affected individuals often exhibit severe developmental delays, early-onset epilepsy, and dysmorphic facial features. Brain imaging frequently reveals dysplasia of the corpus callosum, indicating significant impacts on brain maturation and neuronal development (Wagner2020Biallelic).

The absence of RalGAPA1 protein in fibroblasts from affected individuals suggests a loss-of-function effect, leading to increased RalA activity and a dysfunctional RalGAP complex. This dysregulation impacts neuronal function and brain development, contributing to a group of genetic syndromes termed RALopathies (Wagner2020Biallelic).

In addition to neurodevelopmental disorders, alterations in RALGAPA1 expression have been implicated in metabolic conditions. A mutation at the Thr735 site in RalGAPα1 impairs insulin-stimulated glucose and lipid uptake in skeletal muscle, leading to insulin resistance and metabolic syndrome in mice. This suggests that RALGAPA1 plays a critical role in maintaining glucose and lipid homeostasis, and its dysregulation can contribute to metabolic disorders such as type 2 diabetes (Chen2019Targeting).

## Interactions
RALGAPA1, the catalytic subunit of the Ral GTPase-activating protein (GAP) complex, interacts with several proteins to regulate cellular processes. It forms a complex with RALGAPB, a scaffolding subunit, to exert its GAP function on the small GTPases RalA and RalB. This interaction is crucial for the regulation of RalA activity, as RALGAPA1 facilitates GTP hydrolysis, converting RalA into its inactive GDP-bound form (Wagner2020Biallelic; Chen2019Targeting).

In skeletal muscle, RALGAPA1 interacts with RalGAPB through specific regions, and this interaction is essential for the stability of the RalGAP complex. Disruption of this interaction, such as by the β-blockatide peptide, leads to decreased levels of RALGAPA1 through proteasomal degradation, affecting insulin-stimulated RalA activation and glucose uptake (Chen2019Targeting).

RALGAPA1 is also involved in insulin signaling pathways. It is phosphorylated by PKB in response to insulin, which inactivates RALGAPA1 and increases GTP-loaded active RalA, promoting GLUT4 translocation in muscle cells (Chen2019Targeting). This phosphorylation is critical for regulating CD36 translocation and lipid uptake in response to insulin (Chen2019Targeting).


## References


[1. (Wagner2020Biallelic) Matias Wagner, Yuliya Skorobogatko, Ben Pode-Shakked, Cynthia M. Powell, Bader Alhaddad, Annette Seibt, Ortal Barel, Gali Heimer, Chen Hoffmann, Laurie A. Demmer, Yezmin Perilla-Young, Marc Remke, Dagmar Wieczorek, Tharsini Navaratnarajah, Peter Lichtner, Dirk Klee, Hanan E. Shamseldin, Fuad Al Mutairi, Ertan Mayatepek, Tim Strom, Thomas Meitinger, Fowzan S. Alkuraya, Yair Anikster, Alan R. Saltiel, and Felix Distelmaier. Bi-allelic variants in ralgapa1 cause profound neurodevelopmental disability, muscular hypotonia, infantile spasms, and feeding abnormalities. The American Journal of Human Genetics, 106(2):246–255, February 2020. URL: http://dx.doi.org/10.1016/j.ajhg.2020.01.002, doi:10.1016/j.ajhg.2020.01.002. This article has 17 citations.](https://doi.org/10.1016/j.ajhg.2020.01.002)

[2. (Shimojima2009TULIP1) Keiko Shimojima, Yuta Komoike, Jun Tohyama, Sonoko Takahashi, Marco T. Páez, Eiji Nakagawa, Yuichi Goto, Kousaku Ohno, Mayu Ohtsu, Hirokazu Oguni, Makiko Osawa, Toru Higashinakagawa, and Toshiyuki Yamamoto. Tulip1 (ralgapa1) haploinsufficiency with brain development delay. Genomics, 94(6):414–422, December 2009. URL: http://dx.doi.org/10.1016/j.ygeno.2009.08.015, doi:10.1016/j.ygeno.2009.08.015. This article has 46 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ygeno.2009.08.015)

[3. (Chen2019Targeting) Qiaoli Chen, Ping Rong, Sangsang Zhu, Xinyu Yang, Qian Ouyang, Hong Yu Wang, and Shuai Chen. Targeting ralgapα1 in skeletal muscle to simultaneously improve postprandial glucose and lipid control. Science Advances, April 2019. URL: http://dx.doi.org/10.1126/sciadv.aav4116, doi:10.1126/sciadv.aav4116. This article has 20 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/sciadv.aav4116)